JP2579212B2 - Polycrystalline alumina ceramic for living body - Google Patents
Polycrystalline alumina ceramic for living bodyInfo
- Publication number
- JP2579212B2 JP2579212B2 JP1064296A JP6429689A JP2579212B2 JP 2579212 B2 JP2579212 B2 JP 2579212B2 JP 1064296 A JP1064296 A JP 1064296A JP 6429689 A JP6429689 A JP 6429689A JP 2579212 B2 JP2579212 B2 JP 2579212B2
- Authority
- JP
- Japan
- Prior art keywords
- alumina
- polycrystalline
- polycrystalline alumina
- cell
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Materials For Medical Uses (AREA)
- Dental Prosthetics (AREA)
- Compositions Of Oxide Ceramics (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は緻密に焼結可能で生体親和性に優れる生体用
多結晶アルミナセラミックスに関する。本発明は、人工
骨、人工関節、人工歯根等として人体に直接、埋入又は
接触させて使用し生体機能の回復及び増強を図るアルミ
ナセラミックスを提供することを目的とする。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to polycrystalline alumina ceramics for living bodies which can be densely sintered and have excellent biocompatibility. An object of the present invention is to provide an alumina ceramic which is used as an artificial bone, an artificial joint, an artificial tooth root, or the like, which is directly implanted or in contact with a human body to recover and enhance biological functions.
生体用アルミナセラミックスとして高純度のアルミナ
原料を耐熱容器内に入れて真空中で溶融させることによ
り約99.9%程度の高純度アルミナ単結晶よりなる人工骨
用等の生体セラミックスが知られている(特公昭61−90
74号公報等)。また、アルミナ多結晶生体セラミックス
としては、アルミナ含有量が50〜95%とZrO2等からなる
骨内インプラント用焼成セラミックス組成物が知られて
いる(特公昭51−39654号公報)。Bioceramics such as artificial bones made of high-purity alumina single crystals of about 99.9% by placing a high-purity alumina raw material in a heat-resistant container and melting it in a vacuum are known as alumina ceramics for living bodies. Kuniaki 61-90
No. 74, etc.). Further, as an alumina polycrystalline bioceramic, there is known a fired ceramic composition for an intraosseous implant, which comprises 50 to 95% of alumina and ZrO 2 or the like (Japanese Patent Publication No. 51-39654).
更に、電子部品等の分野において高純度アルミナセラ
ミックとして、Al2O3−SiO2−MgOの3成分系からなりAl
2O399.7〜99.9重量%含有する高周波誘電損失の小さな
もの(特公昭63−66795号公報)、Al2O3−CaO−MgOの3
成分系からなりAl2O399.6〜99.9重量%含有する高周波
Q値が高いもの(特開昭61-118905号公報)が知られて
いる。Further, as a high-purity alumina ceramic in the field of electronic components, etc., it is composed of a three-component system of Al 2 O 3 —SiO 2 —MgO,
2 O 3 containing 99.7 to 99.9% by weight and having a small high-frequency dielectric loss (Japanese Patent Publication No. 63-66795); Al 2 O 3 —CaO—MgO 3
A high-frequency high-frequency Q-factor comprising 99.6 to 99.9% by weight of Al 2 O 3 (JP-A-61-118905) is known.
上記第1の生体用アルミナセラミックスにおいては、
高アルミナ含有量であるが単結晶に関するものである。
一方、多結晶アルミナについては高純度アルミナとなる
と焼結させることが困難となるため、ほとんど検討され
ていない。検討されているのは、いずれも上記第2の骨
内インプラント用のもののようにアルミナ純度の低いも
のばかりである。In the first alumina ceramic for a living body,
High alumina content but for single crystals.
On the other hand, polycrystalline alumina is hardly studied because high-purity alumina becomes difficult to be sintered. Only those having low alumina purity, such as those for the second intraosseous implant, have been studied.
一方、上記電子部品等に利用されるアルミナセラミッ
クスは製法からみて多結晶アルミナからなる。しかし、
これを長期間生体内で使用する場合には、生体に悪影響
を及ぼさないことが重要であるが、どのような組成のア
ルミナセラミックスが生体に適するかについては言及さ
れていない。On the other hand, alumina ceramics used for the above electronic components and the like are made of polycrystalline alumina in view of the manufacturing method. But,
When this is used in a living body for a long period of time, it is important that it does not adversely affect the living body, but there is no mention of what composition of alumina ceramics is suitable for the living body.
本発明は、上記問題点を解消するとともに、種々検討
の結果、ある組成の高純度多結晶アルミナが細胞増殖に
極めて優れることを新たに見出してなされたものであ
り、緻密な焼結体が得られかつ生体為害性がなく生体親
和性に極めて優れる生体用多結晶アルミナセラミックス
を提供することを目的とする。The present invention solves the above problems and, as a result of various studies, newly finds that high-purity polycrystalline alumina having a certain composition is extremely excellent in cell growth, and a dense sintered body is obtained. It is an object of the present invention to provide a polycrystalline alumina ceramic for living organisms which is not harmful to living organisms and has extremely excellent biocompatibility.
本発明の生体用多結晶アルミナセラミックスは、空気
雰囲気下において1250〜1650℃にて焼成されてなる生体
用多結晶アルミナセラミックスであって、酸化アルミニ
ウムの含有量が99.5〜99.9重量%であり残部がMg、Ca、
Sr、Ba、Sc、Y、La及びCeから選択される一種以上の酸
化物及び不可避不純物からなり、且つ多結晶焼結体から
なり、L−929細胞の細胞濃度が2.8×104Cell/mlである
培地3.1mlを用いて上記多結晶アルミナセラミックス板
上で培養した場合において、37℃で播種から3日後の細
胞数が8.5×104個以上となる細胞増殖性を有することを
特徴とする。The biological polycrystalline alumina ceramic of the present invention is a biological polycrystalline alumina ceramic which is fired at 1250 to 1650 ° C. in an air atmosphere, the aluminum oxide content is 99.5 to 99.9% by weight, and the balance is Mg, Ca,
It consists of one or more oxides and unavoidable impurities selected from Sr, Ba, Sc, Y, La and Ce, and consists of a polycrystalline sintered body, and the cell concentration of L-929 cells is 2.8 × 10 4 Cell / ml. When cultured on the above-mentioned polycrystalline alumina ceramics plate using 3.1 ml of a medium, the cells have a cell growth property such that the number of cells three days after seeding at 37 ° C. becomes 8.5 × 10 4 or more. .
尚、本発明において細胞増殖性の評価に用いた上記
「L−929細胞」とは、L細胞の一種であって、CCL1(N
CTC clone 929)を示す。The “L-929 cells” used in the evaluation of cell proliferation in the present invention are a kind of L cells, and include CCL1 (N
CTC clone 929).
本発明者等は、種々検討の結果、アルミナ含有量が9
9.5%以上の多結晶アルミナセラミックスが細胞増殖に
極めて優れること、これを緻密に焼結させるためには、
易焼結性でかつより高純度のアルミナ原料を使用し、適
当な助剤を選択すればよいことという新たな知見を得
た。As a result of various studies, the present inventors found that the alumina content was 9%.
9.5% or more of polycrystalline alumina ceramics is extremely excellent in cell growth, and in order to sinter it densely,
New knowledge has been obtained that an alumina material with higher sinterability and higher purity may be used and an appropriate auxiliary agent may be selected.
即ち、上記組成にすれば細胞増殖のみならず緻密で高
強度で、更に生体為害性もない焼結体を得ることができ
る。That is, with the above composition, it is possible to obtain a sintered body that is dense and has high strength as well as cell growth and that is not harmful to living organisms.
上記のようにアルミナ含有量を99.5%以上とするの
は、細胞培養による増殖が優れ、ひいては生体親和性が
極めて優れるからである。特に、アルミナ含有量が99.7
%以上の場合は、更に良好な細胞増殖を得ることができ
る。更に、Mg、Ca、Sr、Ba、Sc、Y、La及びCeの酸化物
の少なくとも一種とするのは、アルミナの焼結助剤とし
て優れるとともに生体為害性がほとんどないからでもあ
る。The reason why the alumina content is set to 99.5% or more as described above is that the growth by cell culture is excellent, and the biocompatibility is extremely excellent. In particular, the alumina content is 99.7
%, More favorable cell proliferation can be obtained. Further, the use of at least one of oxides of Mg, Ca, Sr, Ba, Sc, Y, La and Ce is because it is excellent as a sintering aid for alumina and has almost no harm to living organisms.
一方、アルミナ含有量の上限を99.9%とするのは、9
9.9%を越える場合は細胞増殖の一層の優位性が得られ
ず安定して焼結することが困難なこと、99.5〜99.9%の
範囲内であれば目的とする多結晶体が得られることのた
めである。On the other hand, the upper limit of alumina content is 99.9%
If it exceeds 9.9%, it is difficult to obtain a more superior cell growth and it is difficult to perform stable sintering. If it is in the range of 99.5 to 99.9%, the desired polycrystal can be obtained. That's why.
更に、この焼結体の原料調製から焼成までの製造工程
において、不可避不純物が混入する危険性があるが、細
胞増殖が安定して良好となるためには、この総混入量が
0.1%以下が好ましい。また、使用するアルミナの平均
粒径は0.1〜1μ程度のものが、易焼結性及び製造容易
性の点で好ましい。焼成温度は1250〜1650℃の範囲であ
り、更に粒成長を極力抑えて十分緻密化させ、かつ強度
を保持するためためには1350〜1500℃の範囲が好まし
い。Furthermore, in the manufacturing process from the preparation of the raw material of the sintered body to the firing, there is a danger that inevitable impurities may be mixed.
0.1% or less is preferable. The average particle size of the alumina used is preferably about 0.1 to 1 μm in terms of easy sintering and easy production. The firing temperature is in the range of 1250 to 1650 ° C., and in order to further suppress grain growth as sufficiently as possible and sufficiently maintain the density, and preferably in the range of 1350 to 1500 ° C.
以下、実施例により本発明を具体的に説明する。アル
ミナ(純度99.999%、平均粒径0.5μ)、炭酸マグネシ
ウム(市販品、試薬特級)、炭酸カルシウム(市販品、
試薬特級)、炭酸ストロンチウム(市販品、試薬特
級)、炭酸バリウム(市販品、試薬特級)、酸化スカン
ジウム(市販品、試薬特級)、酸化イットリウム(市販
品、試薬特級)、酸化ランタン(市販品、試薬特級)、
酸化セリウム(市販品、試薬特級)及び酸化ニッケル
(NiO)の10種を、そのうちの炭酸塩4種を各々MgO、Ca
O、SrO、BaOに換算して、合量で各々1kgとなるように、
表の各割合に秤量し、混合する。その後その混合物に各
々水1、ポリビニルアルコール5g、ポリエチレングリ
コール5gを配合し、内容積2lのポリエチレンポットと純
度99.995%のアルミナ球石2kgを用いて48時間混合し
た。これにより得られた19種類のスラリーを凍結乾燥
し、その後60メッシュの篩によって造粒した。Hereinafter, the present invention will be described specifically with reference to examples. Alumina (purity 99.999%, average particle size 0.5μ), magnesium carbonate (commercially available, special grade reagent), calcium carbonate (commercially available,
Reagent grade), strontium carbonate (commercially available, reagent grade), barium carbonate (commercially available, reagent grade), scandium oxide (commercially available, grade reagent), yttrium oxide (commercially available, grade reagent), lanthanum oxide (commercial grade, Reagent grade),
Ten kinds of cerium oxide (commercially available, special grade reagent) and nickel oxide (NiO) were used, and four kinds of carbonates were MgO and Ca, respectively.
In terms of O, SrO, BaO, so that the total amount is 1 kg each,
Weigh and mix each proportion in the table. Thereafter, water, 1 g of polyvinyl alcohol and 5 g of polyethylene glycol were added to the mixture, and mixed for 2 hours using a polyethylene pot having an internal volume of 2 liters and 2 kg of alumina spheres having a purity of 99.995%. The 19 types of slurries thus obtained were freeze-dried and then granulated with a 60-mesh sieve.
この造粒粉末を1500kg/cm2の金型プレスによって所定
の寸法に成形し、空気炉1250〜1600℃、1時間の焼成を
行って焼結体を得た。この焼結体の化学成分の分析値、
密度、曲げ強度及び3日後の細胞数の結果を表に示し
た。No.1〜No.14は本発明品、No.15〜No.19は比較例で
ある。The granulated powder was formed into a predetermined size by a 1500 kg / cm 2 mold press, and fired in an air furnace at 1250 to 1600 ° C. for 1 hour to obtain a sintered body. Analytical values of chemical components of this sintered body,
The results of density, flexural strength and number of cells after 3 days are shown in the table. Nos. 1 to 14 are products of the present invention, and Nos. 15 to 19 are comparative examples.
曲げ強度は3×4×40mmの焼結体を用い、JISR1601に
準じて測定した。細胞増殖は、細胞濃度が2.8×104Cell
/mlである培地3.1mlを37℃において試料上で培養し、播
種から1日毎に試料上の細胞数を計測した。尚、細胞と
してL−929を用いた。これらの細胞増殖の試験結果を
第1図に示す。The bending strength was measured according to JISR1601 using a sintered body of 3 × 4 × 40 mm. For cell growth, cell concentration was 2.8 × 10 4 Cell
3.1 ml / ml of the medium was cultured on the sample at 37 ° C., and the number of cells on the sample was counted every day from seeding. In addition, L-929 was used as a cell. The results of these cell growth tests are shown in FIG.
表に示すように、アルミナ含有量が99.5%以上でかつ
MgO、CaO、SrO、BaO、Sc2O3、Y2O3、La2O3及びCeO2の少
なくとも一種を添加した場合(No.1〜14)はいずれも、
通常の焼成条件にて3.92g/cm3上の良好に緻密な焼結体
を得ることができ、曲げ強度が52kg/mm2以上であり98.4
%を含有する場合(No.17)と比べて同等またはそれ以
上であり、更に、細胞増殖が99.3%以下の場合(No.15
〜18)と比べると良好な生体親和性を示した。As shown in the table, the alumina content is 99.5% or more and
MgO, CaO, SrO, BaO, either Sc 2 O 3, Y 2 O 3, La 2 O 3 and optionally with the addition of at least one CeO 2 (No.1~14) is
A good dense sintered body on 3.92 g / cm 3 can be obtained under normal firing conditions, and the bending strength is 52 kg / mm 2 or more and 98.4
% (No. 17) or more than 99.3% (No. 15).
~ 18) showed better biocompatibility.
尚、NiOを添加しアルミナ含有量が99.6%の場合(No.
19)はアルミナ含有量が本発明範囲に含まれるに係わら
ず曲げ強度及び細胞増殖率は良くなかった。この少量の
添加においても細胞増殖の低下を来たす点において、上
記本発明組成範囲のものとの差が大きいことを示してい
る。更に、このNiは生体為害性の点でも問題があり、一
方上記CaO等はその心配がない。When NiO was added and the alumina content was 99.6% (No.
In 19), the bending strength and the cell growth rate were not good even though the alumina content was included in the range of the present invention. This shows that the difference from the above composition range of the present invention is large in that the addition of a small amount causes a decrease in cell proliferation. Further, Ni has a problem in terms of harmfulness to living organisms, while the above-mentioned CaO and the like do not have such a concern.
〔発明の効果〕 本発明は、高アルミナ含有量でMg等の所定の添加剤を
所定量配合することにより、多結晶焼結体でも緻密で高
強度で生体為害がない焼結体を製造でき、かつこの焼結
体の細胞増殖率が極めて優れる。従って、本焼結体は生
体に大変好ましいものである。 [Effect of the Invention] The present invention can produce a dense, high-strength sintered body that is not harmful to living organisms even in a polycrystalline sintered body by mixing a predetermined amount of a predetermined additive such as Mg with a high alumina content. In addition, the cell growth rate of this sintered body is extremely excellent. Therefore, the present sintered body is very preferable for a living body.
第1図はアルミナ含有量と3日後の細胞数との関係を示
すグラフである。FIG. 1 is a graph showing the relationship between the alumina content and the number of cells after 3 days.
Claims (1)
成されてなる生体用多結晶アルミナセラミックスであっ
て、酸化アルミニウムの含有量が99.5〜99.9重量%であ
り残部がMg、Ca、Sr、Ba、Sc、Y、La及びCeから選択さ
れる一種以上の酸化物及び不可避不純物からなり、且つ
多結晶焼結体からなり、 L−929細胞の細胞濃度が2.8×104Cell/mlである培値3.
1mlを用いて上記多結晶アルミナセラミックス板上で培
養した場合において、37℃で播種から3日後の細胞数が
8.5×104個以上となる細胞増殖性を有することを特徴と
する生体用多結晶アルミナセラミックス。1. A biological polycrystalline alumina ceramic fired at 1250 to 1650 ° C. in an air atmosphere, wherein the content of aluminum oxide is 99.5 to 99.9% by weight and the balance is Mg, Ca, Sr, It is made of one or more oxides and unavoidable impurities selected from Ba, Sc, Y, La and Ce, and is made of a polycrystalline sintered body. The cell concentration of L-929 cells is 2.8 × 10 4 Cell / ml. Culture value 3.
When cultured on the above polycrystalline alumina ceramics plate using 1 ml, the number of cells 3 days after seeding at 37 ° C.
A biological polycrystalline alumina ceramics having a cell proliferation of 8.5 × 10 4 or more.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1064296A JP2579212B2 (en) | 1989-03-16 | 1989-03-16 | Polycrystalline alumina ceramic for living body |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1064296A JP2579212B2 (en) | 1989-03-16 | 1989-03-16 | Polycrystalline alumina ceramic for living body |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH02243560A JPH02243560A (en) | 1990-09-27 |
JP2579212B2 true JP2579212B2 (en) | 1997-02-05 |
Family
ID=13254139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1064296A Expired - Fee Related JP2579212B2 (en) | 1989-03-16 | 1989-03-16 | Polycrystalline alumina ceramic for living body |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2579212B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3859354B2 (en) * | 1998-04-30 | 2006-12-20 | 日本特殊陶業株式会社 | Spark plug, spark plug insulator and method of manufacturing the same |
US7151606B2 (en) | 2001-07-09 | 2006-12-19 | Mitsui Mining & Smelting Co., Ltd. | Method for evaluation of vegetables and fruits and evaluation apparatus therefor |
JP2006076857A (en) * | 2004-09-13 | 2006-03-23 | National Institute Of Advanced Industrial & Technology | Alumina-boron nitride composite and method for producing the same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62260766A (en) * | 1986-05-08 | 1987-11-13 | 東レ株式会社 | Alumina sintered body |
JPS63174646A (en) * | 1987-01-12 | 1988-07-19 | 住友化学工業株式会社 | Orthodontic material |
JPH0211135A (en) * | 1988-06-29 | 1990-01-16 | Kobe Steel Ltd | Production of artificial bone |
-
1989
- 1989-03-16 JP JP1064296A patent/JP2579212B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH02243560A (en) | 1990-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060178257A1 (en) | Alumina/zirconia ceramics and method of producing the same | |
JP3934750B2 (en) | Oxide ion conductive ceramics and method for producing the same | |
JP2579212B2 (en) | Polycrystalline alumina ceramic for living body | |
JPH05254921A (en) | Beta-alumina solid electrolyte | |
JP3231135B2 (en) | Biological implant material and method for producing the same | |
JPH0696468B2 (en) | Beta-alumina sintered body and method for producing the same | |
GB2228932A (en) | Process for producing dense-sintered cordierite bodies | |
CN1431164A (en) | High performance alumina bioceramic sintered under normal pressure and low temp | |
JP2777679B2 (en) | Spinel ceramics and manufacturing method thereof | |
JPH0794344B2 (en) | Polycrystalline alumina ceramics for living body | |
JP4831945B2 (en) | Zirconia-alumina ceramics and process for producing the same | |
JPH08208317A (en) | Alumina sintered body and production thereof | |
JP2762508B2 (en) | Zirconia sintered body and method for producing the same | |
JPS63277560A (en) | Zro2-mgo-y2o3 ceramic and production thereof | |
JPS59107968A (en) | Manufacture of zirconia ceramics | |
JP4612358B2 (en) | Alumina / zirconia ceramics and production method thereof | |
JPH01115360A (en) | Inorganic living body material and preparation thereof | |
JPH05105463A (en) | Production of crystallized glass | |
JPS63139044A (en) | Alumina-zirconia base sintered body and manufacture | |
JP2858965B2 (en) | Aluminum oxide sintered body | |
JPH01145064A (en) | Preparation of inorganic bio-material | |
JPS6316359B2 (en) | ||
JPH03205363A (en) | Sintered silicon nitride and production thereof | |
JP3059503B2 (en) | Beta-alumina sintered body and method for producing the same | |
JP2811493B2 (en) | Silicon nitride sintered body |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |